A fascinating new preprint discusses the potential for customized serologic testing in individuals who have or have not been vaccinated against the severe acute respiratory syndrome coronavirus 2 ...
A novel coronavirus that was first reported in China in December 2019 quickly led to a global pandemic. Named COVID-19, the virus has had a devastating effect on economies and healthcare systems ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced performance validation and the upcoming launch ...
An icon in the shape of a calendar. A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". MILAN, May 4, 2021 /PRNewswire/ -- To ...
Are you an education worker or a parent? Contact the Cross-Canada Educators Rank-and-File Safety Committee at [email protected] to join the struggle to prevent ongoing mass infection in Canada’s ...
LOS ANGELES, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the discovery, development and commercialization of ...
GENEVA (Reuters) - A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and middle-income countries under a first of its kind agreement to ...
If you are looking for a single magical number to tell whether you can be more lax on Covid-19 precautions, sorry, but the level of antibodies in your blood is not going to provide it. Antibodies aren ...